Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension
Pulmonary arterial hypertension has characteristic changes to the mechanical environment, extracellular matrix, and cellular proliferation. In order to develop a culture system to investigate extracellular matrix (ECM) compositional-dependent changes in pulmonary arterial hypertension, we decellular...
Saved in:
Main Authors: | Patrick A. Link (Author), Laszlo Farkas (Author), Rebecca L. Heise (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct Delivery of MicroRNA96 to the Lungs Reduces Progression of Sugen/Hypoxia-Induced Pulmonary Hypertension in the Rat
by: Craig K. Docherty, et al.
Published: (2020) -
The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan
by: Thomas L. Williams, et al.
Published: (2024) -
MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents
by: Tianji Chen, et al.
Published: (2022) -
From here to there, progenitor cells and stem cells are everywhere in lung vascular remodeling
by: Rebecca L. Heise, et al.
Published: (2016) -
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
by: Daniel Morales-Cano, et al.
Published: (2023)